<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2020-10-07" version="208">
<accession>Q92794</accession>
<accession>Q76L81</accession>
<name>KAT6A_HUMAN</name>
<protein>
<recommendedName>
<fullName>Histone acetyltransferase KAT6A</fullName>
<ecNumber evidence="19 20">2.3.1.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3</fullName>
<shortName>MYST-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Monocytic leukemia zinc finger protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Runt-related transcription factor-binding protein 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Zinc finger protein 220</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">KAT6A</name>
<name type="synonym">MOZ</name>
<name type="synonym">MYST3</name>
<name type="synonym">RUNXBP2</name>
<name type="synonym">ZNF220</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Nat. Genet." volume="14" first="33" last="41">
<title>The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.</title>
<authorList>
<person name="Borrow J."/>
<person name="Stanton V.P. Jr."/>
<person name="Andresen J.M."/>
<person name="Becher R."/>
<person name="Behm F.G."/>
<person name="Chaganti R.S.K."/>
<person name="Civin C.I."/>
<person name="Disteche C."/>
<person name="Dube I."/>
<person name="Frischauf A.M."/>
<person name="Horsman D."/>
<person name="Mitelman F."/>
<person name="Volinia S."/>
<person name="Watmore A.E."/>
<person name="Housman D.E."/>
</authorList>
<dbReference type="PubMed" id="8782817"/>
<dbReference type="DOI" id="10.1038/ng0996-33"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH CREBBP</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2002-04" db="EMBL/GenBank/DDBJ databases">
<title>MOZ is fused to a novel Polycomb group gene in a therapy-related myelodysplastic syndrome with t(2;8)(p23;p11.2).</title>
<authorList>
<person name="Hosoda F."/>
<person name="Kitabayashi I."/>
<person name="Kakazu N."/>
<person name="Fukushima M."/>
<person name="Aikawa Y."/>
<person name="Abe T."/>
<person name="Hibi S."/>
<person name="Yagi T."/>
<person name="Ohki M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-813</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH ASXL2</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="Blood" volume="91" first="3127" last="3133">
<title>A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.</title>
<authorList>
<person name="Carapeti M."/>
<person name="Aguiar R.C.T."/>
<person name="Goldman J.M."/>
<person name="Cross N.C.P."/>
</authorList>
<dbReference type="PubMed" id="9558366"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1089-1117</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH NCOA2</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2000" name="Genes Chromosomes Cancer" volume="28" first="138" last="144">
<title>MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).</title>
<authorList>
<person name="Chaffanet M."/>
<person name="Gressin L."/>
<person name="Preudhomme C."/>
<person name="Soenen-Cornu V."/>
<person name="Birnbaum D."/>
<person name="Pebusque M.-J."/>
</authorList>
<dbReference type="PubMed" id="10824998"/>
<dbReference type="DOI" id="10.1002/(sici)1098-2264(200006)28:2&lt;138::aid-gcc2&gt;3.0.co;2-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1111-1128</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH EP300</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="7184" last="7196">
<title>Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.</title>
<authorList>
<person name="Kitabayashi I."/>
<person name="Aikawa Y."/>
<person name="Nguyen L.A."/>
<person name="Yokoyama A."/>
<person name="Ohki M."/>
</authorList>
<dbReference type="PubMed" id="11742995"/>
<dbReference type="DOI" id="10.1093/emboj/20.24.7184"/>
</citation>
<scope>INTERACTION WITH RUNX1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACETYLATION</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH CREBBP</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Oncogene" volume="20" first="404" last="409">
<title>The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase.</title>
<authorList>
<person name="Champagne N."/>
<person name="Pelletier N."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="11313971"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204114"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="2729" last="2740">
<title>MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2.</title>
<authorList>
<person name="Pelletier N."/>
<person name="Champagne N."/>
<person name="Stifani S."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="11965546"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205367"/>
</citation>
<scope>INTERACTION WITH RUNX2</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Cancer Cell" volume="3" first="259" last="271">
<title>MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.</title>
<authorList>
<person name="Deguchi K."/>
<person name="Ayton P.M."/>
<person name="Carapeti M."/>
<person name="Kutok J.L."/>
<person name="Snyder C.S."/>
<person name="Williams I.R."/>
<person name="Cross N.C.P."/>
<person name="Glass C.K."/>
<person name="Cleary M.L."/>
<person name="Gilliland D.G."/>
</authorList>
<dbReference type="PubMed" id="12676584"/>
<dbReference type="DOI" id="10.1016/s1535-6108(03)00051-5"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH NCOA2</scope>
<scope>MUTAGENESIS OF CYS-543 AND GLY-657</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Nucleic Acids Res." volume="31" first="2735" last="2744">
<title>Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.</title>
<authorList>
<person name="Bristow C.A.P."/>
<person name="Shore P."/>
</authorList>
<dbReference type="PubMed" id="12771199"/>
<dbReference type="DOI" id="10.1093/nar/gkg401"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="988" last="1002">
<title>MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.</title>
<authorList>
<person name="Kindle K.B."/>
<person name="Troke P.J.F."/>
<person name="Collins H.M."/>
<person name="Matsuda S."/>
<person name="Bossi D."/>
<person name="Bellodi C."/>
<person name="Kalkhoven E."/>
<person name="Salomoni P."/>
<person name="Pelicci P.G."/>
<person name="Minucci S."/>
<person name="Heery D.M."/>
</authorList>
<dbReference type="PubMed" id="15657427"/>
<dbReference type="DOI" id="10.1128/mcb.25.3.988-1002.2005"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH NCOA2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="51" last="64">
<title>ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.</title>
<authorList>
<person name="Doyon Y."/>
<person name="Cayrou C."/>
<person name="Ullah M."/>
<person name="Landry A.-J."/>
<person name="Cote V."/>
<person name="Selleck W."/>
<person name="Lane W.S."/>
<person name="Tan S."/>
<person name="Yang X.-J."/>
<person name="Cote J."/>
</authorList>
<dbReference type="PubMed" id="16387653"/>
<dbReference type="DOI" id="10.1016/j.molcel.2005.12.007"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE MOZ/MORF COMPLEX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="6828" last="6843">
<title>Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes.</title>
<authorList>
<person name="Ullah M."/>
<person name="Pelletier N."/>
<person name="Xiao L."/>
<person name="Zhao S.P."/>
<person name="Wang K."/>
<person name="Degerny C."/>
<person name="Tahmasebi S."/>
<person name="Cayrou C."/>
<person name="Doyon Y."/>
<person name="Goh S.-L."/>
<person name="Champagne N."/>
<person name="Cote J."/>
<person name="Yang X.-J."/>
</authorList>
<dbReference type="PubMed" id="18794358"/>
<dbReference type="DOI" id="10.1128/mcb.01297-08"/>
</citation>
<scope>IDENTIFICATION IN THE MOZ/MORF COMPLEX</scope>
<scope>INTERACTION WITH BRPF1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-350; LYS-355 AND LYS-1007</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-473 AND SER-1113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420; SER-473; SER-812; SER-941; SER-954; SER-974; SER-1089; SER-1090 AND SER-1113</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="3895" last="3900">
<title>MOZ increases p53 acetylation and premature senescence through its complex formation with PML.</title>
<authorList>
<person name="Rokudai S."/>
<person name="Laptenko O."/>
<person name="Arnal S.M."/>
<person name="Taya Y."/>
<person name="Kitabayashi I."/>
<person name="Prives C."/>
</authorList>
<dbReference type="PubMed" id="23431171"/>
<dbReference type="DOI" id="10.1073/pnas.1300490110"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PML AND TP53</scope>
<scope>PHOSPHORYLATION AT THR-369</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="96" first="498" last="506">
<title>De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.</title>
<authorList>
<consortium name="UCLA Clinical Genomics Center"/>
<person name="Arboleda V.A."/>
<person name="Lee H."/>
<person name="Dorrani N."/>
<person name="Zadeh N."/>
<person name="Willis M."/>
<person name="Macmurdo C.F."/>
<person name="Manning M.A."/>
<person name="Kwan A."/>
<person name="Hudgins L."/>
<person name="Barthelemy F."/>
<person name="Miceli M.C."/>
<person name="Quintero-Rivera F."/>
<person name="Kantarci S."/>
<person name="Strom S.P."/>
<person name="Deignan J.L."/>
<person name="Grody W.W."/>
<person name="Vilain E."/>
<person name="Nelson S.F."/>
</authorList>
<dbReference type="PubMed" id="25728775"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.01.017"/>
</citation>
<scope>INVOLVEMENT IN ARTHS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="96" first="507" last="513">
<title>Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.</title>
<authorList>
<person name="Tham E."/>
<person name="Lindstrand A."/>
<person name="Santani A."/>
<person name="Malmgren H."/>
<person name="Nesbitt A."/>
<person name="Dubbs H.A."/>
<person name="Zackai E.H."/>
<person name="Parker M.J."/>
<person name="Millan F."/>
<person name="Rosenbaum K."/>
<person name="Wilson G.N."/>
<person name="Nordgren A."/>
</authorList>
<dbReference type="PubMed" id="25728777"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.01.016"/>
</citation>
<scope>INVOLVEMENT IN ARTHS</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-834 AND LYS-1342</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="submission" date="2002-06" db="PDB data bank">
<title>Solution structure of a CCCCCHC zinc finger from MOZ.</title>
<authorList>
<person name="Kwan A.H.Y."/>
<person name="Gell D.A."/>
<person name="Liew C.K."/>
<person name="Mackay J.P."/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 531-563</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="36603" last="36613">
<title>The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting.</title>
<authorList>
<person name="Holbert M.A."/>
<person name="Sikorski T."/>
<person name="Carten J."/>
<person name="Snowflack D."/>
<person name="Hodawadekar S."/>
<person name="Marmorstein R."/>
</authorList>
<dbReference type="PubMed" id="17925393"/>
<dbReference type="DOI" id="10.1074/jbc.m705812200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 501-784 IN COMPLEXES WITH ACETYL-COA; HISTONE H3 AND HISTONE H4 AND ZINC IONS</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>DNA-BINDING</scope>
<scope>MUTAGENESIS OF LYS-545; ILE-727 AND HIS-732</scope>
</reference>
<reference key="27">
<citation type="submission" date="2009-02" db="PDB data bank">
<title>The crystal structure of human MYST histone acetyltransferase 3 in complex with acetylcoenzyme A.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 497-780 IN COMPLEX WITH ACETYL-COA</scope>
<scope>ACETYLATION AT LYS-604</scope>
</reference>
<comment type="function">
<text evidence="20 21 23 24 25 27">Histone acetyltransferase that acetylates lysine residues in histone H3 and histone H4 (in vitro). Component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. May act as a transcriptional coactivator for RUNX1 and RUNX2. Acetylates p53/TP53 at 'Lys-120' and 'Lys-382' and controls its transcriptional activity via association with PML.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="19 20 25">
<text>acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-lysyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:45948"/>
<dbReference type="Rhea" id="RHEA-COMP:9752"/>
<dbReference type="Rhea" id="RHEA-COMP:10731"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57287"/>
<dbReference type="ChEBI" id="CHEBI:57288"/>
<dbReference type="ChEBI" id="CHEBI:61930"/>
<dbReference type="EC" id="2.3.1.48"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="20 21 24 26 27 31">Component of the MOZ/MORF complex composed at least of ING5, KAT6A, KAT6B, MEAF6 and one of BRPF1, BRD1/BRPF2 and BRPF3. Interacts with RUNX1; phosphorylation of RUNX1 enhances the interaction. Interacts with RUNX2. Interacts with p53/TP53. Interacts with PML (isoform PML-4) and this interaction positively regulates its acetylation activity towards p53/TP53.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948013">
<id>Q92794</id>
</interactant>
<interactant intactId="EBI-2638616">
<id>PRO_0000390950</id>
<label>KMT2A</label>
<dbReference type="UniProtKB" id="Q03164"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-948013">
<id>Q92794</id>
</interactant>
<interactant intactId="EBI-540834">
<id>P61964</id>
<label>WDR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>PML body</location>
</subcellularLocation>
<text>Recruited into PML body after DNA damage.</text>
</comment>
<comment type="domain">
<text evidence="19">The N-terminus is involved in transcriptional activation while the C-terminus is involved in transcriptional repression.</text>
</comment>
<comment type="PTM">
<text evidence="14 31">Autoacetylation at Lys-604 is required for proper function (By similarity). Autoacetylated.</text>
</comment>
<comment type="PTM">
<text evidence="20 27">Phosphorylation at Thr-369 by PKB/AKT1 inhibits its interaction with PML and negatively regulates its acetylation activity towards p53/TP53.</text>
</comment>
<comment type="disease">
<text evidence="18 20 22 30">Chromosomal aberrations involving KAT6A may be a cause of acute myeloid leukemias. Translocation t(8;16)(p11;p13) with CREBBP (PubMed:8782817). Translocation t(8;22)(p11;q13) with EP300 (PubMed:10824998). KAT6A-CREBBP may induce leukemia by inhibiting RUNX1-mediated transcription (PubMed:11742995). Inversion inv(8)(p11;q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation (PubMed:12676584).</text>
</comment>
<comment type="disease">
<text evidence="32">A chromosomal aberration involving KAT6A is a cause of therapy-related myelodysplastic syndrome. Translocation t(2;8)(p23;p11.2) with ASXL2 generates a KAT6A-ASXL2 fusion protein.</text>
</comment>
<comment type="disease" evidence="28 29">
<disease id="DI-04351">
<name>Arboleda-Tham syndrome</name>
<acronym>ARTHS</acronym>
<description>An autosomal dominant disorder characterized by intellectual disability, dysmorphic facial features, delayed psychomotor development, and lack of speech.</description>
<dbReference type="MIM" id="616268"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="33">Belongs to the MYST (SAS/MOZ) family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MYST3ID25ch8p11.html"/>
</comment>
<dbReference type="EC" id="2.3.1.48" evidence="19 20"/>
<dbReference type="EMBL" id="U47742">
<property type="protein sequence ID" value="AAC50662.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC090571">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB084281">
<property type="protein sequence ID" value="BAD00088.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6124.1"/>
<dbReference type="RefSeq" id="NP_006757.2">
<property type="nucleotide sequence ID" value="NM_006766.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016869352.1">
<property type="nucleotide sequence ID" value="XM_017013863.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016869353.1">
<property type="nucleotide sequence ID" value="XM_017013864.1"/>
</dbReference>
<dbReference type="PDB" id="1M36">
<property type="method" value="NMR"/>
<property type="chains" value="A=533-563"/>
</dbReference>
<dbReference type="PDB" id="2LN0">
<property type="method" value="NMR"/>
<property type="chains" value="A=204-313"/>
</dbReference>
<dbReference type="PDB" id="2OZU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=497-780"/>
</dbReference>
<dbReference type="PDB" id="2RC4">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=501-784"/>
</dbReference>
<dbReference type="PDB" id="3V43">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.47"/>
<property type="chains" value="A=204-313"/>
</dbReference>
<dbReference type="PDB" id="4LJN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="4LK9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="4LKA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.61"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="4LLB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=194-323"/>
</dbReference>
<dbReference type="PDB" id="5B75">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="5B76">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="5B77">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDB" id="5B78">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=194-323"/>
</dbReference>
<dbReference type="PDBsum" id="1M36"/>
<dbReference type="PDBsum" id="2LN0"/>
<dbReference type="PDBsum" id="2OZU"/>
<dbReference type="PDBsum" id="2RC4"/>
<dbReference type="PDBsum" id="3V43"/>
<dbReference type="PDBsum" id="4LJN"/>
<dbReference type="PDBsum" id="4LK9"/>
<dbReference type="PDBsum" id="4LKA"/>
<dbReference type="PDBsum" id="4LLB"/>
<dbReference type="PDBsum" id="5B75"/>
<dbReference type="PDBsum" id="5B76"/>
<dbReference type="PDBsum" id="5B77"/>
<dbReference type="PDBsum" id="5B78"/>
<dbReference type="BMRB" id="Q92794"/>
<dbReference type="SMR" id="Q92794"/>
<dbReference type="BioGRID" id="113703">
<property type="interactions" value="45"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-727">
<property type="entry name" value="MOZ1 histone acetyltransferase complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-733">
<property type="entry name" value="MOZ2 histone acetyltransferase complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-736">
<property type="entry name" value="MOZ3 histone acetyltransferase complex"/>
</dbReference>
<dbReference type="CORUM" id="Q92794"/>
<dbReference type="IntAct" id="Q92794">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000380136"/>
<dbReference type="ChEMBL" id="CHEMBL3774298"/>
<dbReference type="iPTMnet" id="Q92794"/>
<dbReference type="PhosphoSitePlus" id="Q92794"/>
<dbReference type="BioMuta" id="KAT6A"/>
<dbReference type="DMDM" id="215274095"/>
<dbReference type="EPD" id="Q92794"/>
<dbReference type="jPOST" id="Q92794"/>
<dbReference type="MassIVE" id="Q92794"/>
<dbReference type="MaxQB" id="Q92794"/>
<dbReference type="PaxDb" id="Q92794"/>
<dbReference type="PeptideAtlas" id="Q92794"/>
<dbReference type="PRIDE" id="Q92794"/>
<dbReference type="ProteomicsDB" id="75473"/>
<dbReference type="Antibodypedia" id="23986">
<property type="antibodies" value="133 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="7994"/>
<dbReference type="Ensembl" id="ENST00000265713">
<property type="protein sequence ID" value="ENSP00000265713"/>
<property type="gene ID" value="ENSG00000083168"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396930">
<property type="protein sequence ID" value="ENSP00000380136"/>
<property type="gene ID" value="ENSG00000083168"/>
</dbReference>
<dbReference type="GeneID" id="7994"/>
<dbReference type="KEGG" id="hsa:7994"/>
<dbReference type="UCSC" id="uc003xon.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7994"/>
<dbReference type="DisGeNET" id="7994"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000083168.9"/>
<dbReference type="GeneCards" id="KAT6A"/>
<dbReference type="HGNC" id="HGNC:13013">
<property type="gene designation" value="KAT6A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000083168">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="KAT6A"/>
<dbReference type="MIM" id="601408">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="616268">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92794"/>
<dbReference type="OpenTargets" id="ENSG00000083168"/>
<dbReference type="Orphanet" id="370026">
<property type="disease" value="Acute myeloid leukemia with t(8;16)(p11;p13) translocation"/>
</dbReference>
<dbReference type="Orphanet" id="457193">
<property type="disease" value="Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA37592"/>
<dbReference type="eggNOG" id="KOG2747">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156962"/>
<dbReference type="HOGENOM" id="CLU_001232_0_1_1"/>
<dbReference type="InParanoid" id="Q92794"/>
<dbReference type="KO" id="K11305"/>
<dbReference type="OMA" id="MHVEAEE"/>
<dbReference type="OrthoDB" id="629545at2759"/>
<dbReference type="PhylomeDB" id="Q92794"/>
<dbReference type="TreeFam" id="TF106483"/>
<dbReference type="PathwayCommons" id="Q92794"/>
<dbReference type="Reactome" id="R-HSA-3214847">
<property type="pathway name" value="HATs acetylate histones"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804758">
<property type="pathway name" value="Regulation of TP53 Activity through Acetylation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q92794"/>
<dbReference type="BioGRID-ORCS" id="7994">
<property type="hits" value="57 hits in 864 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="KAT6A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q92794"/>
<dbReference type="GeneWiki" id="MYST3"/>
<dbReference type="GenomeRNAi" id="7994"/>
<dbReference type="Pharos" id="Q92794">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q92794"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="RNAct" id="Q92794">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000083168">
<property type="expression patterns" value="Expressed in cerebral cortex and 255 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q92794">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92794">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000123">
<property type="term" value="C:histone acetyltransferase complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042025">
<property type="term" value="C:host cell nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0070776">
<property type="term" value="C:MOZ/MORF histone acetyltransferase complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000786">
<property type="term" value="C:nucleosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016407">
<property type="term" value="F:acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010485">
<property type="term" value="F:H4 histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090398">
<property type="term" value="P:cellular senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006323">
<property type="term" value="P:DNA packaging"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016573">
<property type="term" value="P:histone acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043966">
<property type="term" value="P:histone H3 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006334">
<property type="term" value="P:nucleosome assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006473">
<property type="term" value="P:protein acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901796">
<property type="term" value="P:regulation of signal transduction by p53 class mediator"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00489"/>
<dbReference type="InterPro" id="IPR016181">
<property type="entry name" value="Acyl_CoA_acyltransferase"/>
</dbReference>
<dbReference type="InterPro" id="IPR002717">
<property type="entry name" value="HAT_MYST-type"/>
</dbReference>
<dbReference type="InterPro" id="IPR005818">
<property type="entry name" value="Histone_H1/H5_H15"/>
</dbReference>
<dbReference type="InterPro" id="IPR031280">
<property type="entry name" value="KAT6A"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR040706">
<property type="entry name" value="Zf-MYST"/>
</dbReference>
<dbReference type="InterPro" id="IPR011011">
<property type="entry name" value="Znf_FYVE_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR001965">
<property type="entry name" value="Znf_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR019787">
<property type="entry name" value="Znf_PHD-finger"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10615:SF26">
<property type="entry name" value="PTHR10615:SF26"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01853">
<property type="entry name" value="MOZ_SAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00628">
<property type="entry name" value="PHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF17772">
<property type="entry name" value="zf-MYST"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00526">
<property type="entry name" value="H15"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00249">
<property type="entry name" value="PHD"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55729">
<property type="entry name" value="SSF55729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57903">
<property type="entry name" value="SSF57903"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS51504">
<property type="entry name" value="H15"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51726">
<property type="entry name" value="MYST_HAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01359">
<property type="entry name" value="ZF_PHD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50016">
<property type="entry name" value="ZF_PHD_2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Histone acetyltransferase KAT6A" id="PRO_0000051572">
<location>
<begin position="1"/>
<end position="2004"/>
</location>
</feature>
<feature type="domain" description="H15" evidence="16">
<location>
<begin position="95"/>
<end position="171"/>
</location>
</feature>
<feature type="domain" description="MYST-type HAT" evidence="17">
<location>
<begin position="504"/>
<end position="778"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type 1" evidence="15">
<location>
<begin position="206"/>
<end position="265"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type 2" evidence="15">
<location>
<begin position="259"/>
<end position="313"/>
</location>
</feature>
<feature type="zinc finger region" description="C2HC MYST-type" evidence="17">
<location>
<begin position="537"/>
<end position="562"/>
</location>
</feature>
<feature type="region of interest" description="Required for activation of RUNX1-1">
<location>
<begin position="1"/>
<end position="144"/>
</location>
</feature>
<feature type="region of interest" description="Required for nuclear localization">
<location>
<begin position="52"/>
<end position="166"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PML" evidence="27">
<location>
<begin position="144"/>
<end position="664"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RUNX1-1">
<location>
<begin position="312"/>
<end position="664"/>
</location>
</feature>
<feature type="region of interest" description="Catalytic">
<location>
<begin position="488"/>
<end position="778"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with BRPF1, required for histone H3 acetyltransferase activity" evidence="26">
<location>
<begin position="507"/>
<end position="810"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="31">
<location>
<begin position="645"/>
<end position="649"/>
</location>
</feature>
<feature type="region of interest" description="Acetyl-CoA binding" evidence="31">
<location>
<begin position="654"/>
<end position="660"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PML" evidence="27">
<location>
<begin position="1517"/>
<end position="1741"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RUNX1-2">
<location>
<begin position="1517"/>
<end position="1642"/>
</location>
</feature>
<feature type="region of interest" description="Required for activation of RUNX1-2">
<location>
<begin position="1913"/>
<end position="1948"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="371"/>
<end position="379"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="788"/>
<end position="801"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="989"/>
<end position="995"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="1019"/>
<end position="1026"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1069"/>
<end position="1078"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Lys">
<location>
<begin position="1147"/>
<end position="1150"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="1221"/>
<end position="1242"/>
</location>
</feature>
<feature type="compositionally biased region" description="Glu-rich">
<location>
<begin position="1267"/>
<end position="1302"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Glu">
<location>
<begin position="1411"/>
<end position="1414"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="1593"/>
<end position="1597"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gln/Pro-rich">
<location>
<begin position="1643"/>
<end position="1704"/>
</location>
</feature>
<feature type="compositionally biased region" description="Met-rich">
<location>
<begin position="1897"/>
<end position="1977"/>
</location>
</feature>
<feature type="active site" description="Proton donor/acceptor" evidence="14">
<location>
<position position="680"/>
</location>
</feature>
<feature type="binding site" description="Acetyl-CoA" evidence="31">
<location>
<position position="684"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6A-ASXL2">
<location>
<begin position="813"/>
<end position="814"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6A-EP300 and KAT6A-NCOA2">
<location>
<begin position="1117"/>
<end position="1118"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form KAT6A-CREBBP">
<location>
<begin position="1546"/>
<end position="1547"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="13">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="350"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="355"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKB/AKT1" evidence="27">
<location>
<position position="369"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="420"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 10">
<location>
<position position="473"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by autocatalysis" evidence="31">
<location>
<position position="604"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="787"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="812"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="13">
<location>
<position position="815"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="899"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="941"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="954"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="974"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="7">
<location>
<position position="1007"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1089"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1090"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 9 10">
<location>
<position position="1113"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11">
<location>
<position position="834"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11">
<location>
<position position="1342"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3824276." id="VAR_047548">
<original>L</original>
<variation>S</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates HAT activity." evidence="22">
<original>C</original>
<variation>G</variation>
<location>
<position position="543"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced affinity for DNA." evidence="25">
<original>K</original>
<variation>A</variation>
<location>
<position position="545"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates HAT activity." evidence="22">
<original>G</original>
<variation>E</variation>
<location>
<position position="657"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduced affinity for DNA." evidence="25">
<original>I</original>
<variation>E</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced affinity for DNA." evidence="25">
<original>H</original>
<variation>D</variation>
<location>
<position position="732"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50662 and 3; BAD00088." ref="1 3" evidence="33">
<original>K</original>
<variation>R</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="198"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="207"/>
<end position="209"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="210"/>
<end position="212"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="239"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="246"/>
<end position="252"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="253"/>
<end position="256"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="260"/>
<end position="262"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="266"/>
<end position="268"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="275"/>
<end position="277"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="282"/>
<end position="284"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="290"/>
<end position="292"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="293"/>
<end position="295"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="308"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="511"/>
<end position="514"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="517"/>
<end position="520"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="529"/>
<end position="532"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="535"/>
<end position="539"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="541"/>
<end position="543"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="546"/>
<end position="549"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="550"/>
<end position="559"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="566"/>
<end position="573"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="576"/>
<end position="582"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="583"/>
<end position="585"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="587"/>
<end position="598"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="613"/>
<end position="622"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="625"/>
<end position="637"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="642"/>
<end position="649"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="651"/>
<end position="653"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="655"/>
<end position="657"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="658"/>
<end position="672"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="677"/>
<end position="679"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="685"/>
<end position="705"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="713"/>
<end position="720"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="724"/>
<end position="733"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="750"/>
<end position="759"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="771"/>
<end position="773"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OZU"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2RC4"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4LK9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5B76"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5B78"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5TKR9"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8BZ21"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9H7Z6"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00146"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00837"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01063"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10824998"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11313971"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11742995"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11965546"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12676584"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12771199"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16387653"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17925393"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18794358"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23431171"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25728775"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25728777"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8782817"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source ref="27"/>
</evidence>
<evidence key="32" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="33" type="ECO:0000305"/>
<sequence length="2004" mass="225028" checksum="78357EFAC4698A5F" modified="2008-11-25" version="2">MVKLANPLYTEWILEAIKKVKKQKQRPSEERICNAVSSSHGLDRKTVLEQLELSVKDGTILKVSNKGLNSYKDPDNPGRIALPKPRNHGKLDNKQNVDWNKLIKRAVEGLAESGGSTLKSIERFLKGQKDVSALFGGSAASGFHQQLRLAIKRAIGHGRLLKDGPLYRLNTKATNVDGKESCESLSCLPPVSLLPHEKDKPVAEPIPICSFCLGTKEQNREKKPEELISCADCGNSGHPSCLKFSPELTVRVKALRWQCIECKTCSSCRDQGKNADNMLFCDSCDRGFHMECCDPPLTRMPKGMWICQICRPRKKGRKLLQKKAAQIKRRYTNPIGRPKNRLKKQNTVSKGPFSKVRTGPGRGRKRKITLSSQSASSSSEEGYLERIDGLDFCRDSNVSLKFNKKTKGLIDGLTKFFTPSPDGRKARGEVVDYSEQYRIRKRGNRKSSTSDWPTDNQDGWDGKQENEERLFGSQEIMTEKDMELFRDIQEQALQKVGVTGPPDPQVRCPSVIEFGKYEIHTWYSSPYPQEYSRLPKLYLCEFCLKYMKSRTILQQHMKKCGWFHPPANEIYRKNNISVFEVDGNVSTIYCQNLCLLAKLFLDHKTLYYDVEPFLFYVLTQNDVKGCHLVGYFSKEKHCQQKYNVSCIMILPQYQRKGYGRFLIDFSYLLSKREGQAGSPEKPLSDLGRLSYMAYWKSVILECLYHQNDKQISIKKLSKLTGICPQDITSTLHHLRMLDFRSDQFVIIRREKLIQDHMAKLQLNLRPVDVDPECLRWTPVIVSNSVVSEEEEEEAEEGENEEPQCQERELEISVGKSVSHENKEQDSYSVESEKKPEVMAPVSSTRLSKQVLPHDSLPANSQPSRRGRWGRKNRKTQERFGDKDSKLLLEETSSAPQEQYGECGEKSEATQEQYTESEEQLVASEEQPSQDGKPDLPKRRLSEGVEPWRGQLKKSPEALKCRLTEGSERLPRRYSEGDRAVLRGFSESSEEEEEPESPRSSSPPILTKPTLKRKKPFLHRRRRVRKRKHHNSSVVTETISETTEVLDEPFEDSDSERPMPRLEPTFEIDEEEEEEDENELFPREYFRRLSSQDVLRCQSSSKRKSKDEEEDEESDDADDTPILKPVSLLRKRDVKNSPLEPDTSTPLKKKKGWPKGKSRKPIHWKKRPGRKPGFKLSREIMPVSTQACVIEPIVSIPKAGRKPKIQESEETVEPKEDMPLPEERKEEEEMQAEAEEAEEGEEEDAASSEVPAASPADSSNSPETETKEPEVEEEEEKPRVSEEQRQSEEEQQELEEPEPEEEEDAAAETAQNDDHDADDEDDGHLESTKKKELEEQPTREDVKEEPGVQESFLDANMQKSREKIKDKEETELDSEEEQPSHDTSVVSEQMAGSEDDHEEDSHTKEELIELKEEEEIPHSELDLETVQAVQSLTQEESSEHEGAYQDCEETLAACQTLQSYTQADEDPQMSMVEDCHASEHNSPISSVQSHPSQSVRSVSSPNVPALESGYTQISPEQGSLSAPSMQNMETSPMMDVPSVSDHSQQVVDSGFSDLGSIESTTENYENPSSYDSTMGGSICGNSSSQSSCSYGGLSSSSSLTQSSCVVTQQMASMGSSCSMMQQSSVQPAANCSIKSPQSCVVERPPSNQQQQPPPPPPQQPQPPPPQPQPAPQPPPPQQQPQQQPQPQPQQPPPPPPPQQQPPLSQCSMNNSFTPAPMIMEIPESGSTGNISIYERIPGDFGAGSYSQPSATFSLAKLQQLTNTIMDPHAMPYSHSPAVTSYATSVSLSNTGLAQLAPSHPLAGTPQAQATMTPPPNLASTTMNLTSPLLQCNMSATNIGIPHTQRLQGQMPVKGHISIRSKSAPLPSAAAHQQQLYGRSPSAVAMQAGPRALAVQRGMNMGVNLMPTPAYNVNSMNMNTLNAMNSYRMTQPMMNSSYHSNPAYMNQTAQYPMQMQMGMMGSQAYTQQPMQPNPHGNMMYTGPSHHSYMNAAGVPKQSLNGPYMRR</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

